We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$169M
AUM Growth
-$69.7M
Cap. Flow
-$68M
Cap. Flow %
-40.18%
Top 10 Hldgs %
42.32%
Holding
107
New
38
Increased
7
Reduced
15
Closed
41

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$5.66M
2
EW icon
Edwards Lifesciences
EW
+$3.26M
3
SIEN
Sientra, Inc.
SIEN
+$3.25M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$3M
5
QGEN icon
Qiagen
QGEN
+$2.48M

Top Sells

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$6.09M
2
HCA icon
HCA Healthcare
HCA
+$3.95M
3
BSX icon
Boston Scientific
BSX
+$3.87M
4
HOLX
Hologic
HOLX
+$3.85M
5
ATHN
Athenahealth, Inc.
ATHN
+$3.42M

Sector Composition

Rank Sector Weight
1 Healthcare 51.93%
2 Industrials 2.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FXH icon
76
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
– –
-130,000
Closed -$9.07M
GMED icon
77
CALL
Globus Medical
GMED
$11.4B
– –
-78,600
Closed -$3.23M
GYRE icon
78
Gyre Therapeutics
GYRE
$704M
– –
-8,000
Closed -$818K
HCA icon
79
CALL
HCA Healthcare
HCA
$89.1B
– –
-25,000
Closed -$2.2M
HCA icon
80
HCA Healthcare
HCA
$89.1B
– –
-45,000
Closed -$3.95M
HOLX
81
DELISTED
Hologic
HOLX
– –
-90,000
Closed -$3.85M
IBB icon
82
PUT
iShares Biotechnology ETF
IBB
$9.81B
– –
-65,000
Closed -$6.94M
ISRG icon
83
CALL
Intuitive Surgical
ISRG
$142B
– –
-24,000
Closed -$2.92M
IWM icon
84
PUT
iShares Russell 2000 ETF
IWM
$81.8B
– –
-47,500
Closed -$7.24M
KURA icon
85
Kura Oncology
KURA
$882M
– –
-50,000
Closed -$765K
LIVN icon
86
CALL
LivaNova
LIVN
$4.33B
– –
-128,000
Closed -$10.2M
MEDP icon
87
Medpace
MEDP
$16.9B
– –
-70,000
Closed -$2.54M
OSIS icon
88
CALL
OSI Systems
OSIS
$3.84B
– –
-201,500
Closed -$13M
PBYI icon
89
Puma Biotechnology
PBYI
$453M
– –
-10,000
Closed -$989K
PEN icon
90
Penumbra
PEN
$12.9B
– –
-15,000
Closed -$1.41M
PODD icon
91
Insulet
PODD
$10B
– –
-40,000
Closed -$2.76M
QTRX icon
92
Quanterix
QTRX
$124M
– –
-49,300
Closed -$1.06M
REGN icon
93
Regeneron Pharmaceuticals
REGN
$82.1B
– –
-5,000
Closed -$1.88M
VNDA icon
94
PUT
Vanda Pharmaceuticals
VNDA
$298M
– –
-300,000
Closed -$4.56M
WBA
95
CALL
DELISTED
Walgreens Boots Alliance
WBA
– –
-65,000
Closed -$4.72M
XBI icon
96
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
– –
-87,500
Closed -$7.43M
XRAY icon
97
Dentsply Sirona
XRAY
$2.31B
– –
-92,500
Closed -$6.09M
DCPH
98
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-68,154
Closed -$1.54M
NSTG
99
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-29,300
Closed -$219K
ACOR
100
DELISTED
Acorda Therapeutics
ACOR
– –
-292
Closed -$751K
1 2 3
4
5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2018 Portfolio in Review

As of Q1 2018, Pura Vida Investments held 107 positions worth $169M, down 29% from $239M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Pura Vida Investments withdrew a net $68M in Q1 2018, closing 41 positions and reducing 15 holdings. Its most notable exit was Dentsply Sirona, an estimated $6.09M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 46% a quarter earlier, followed by Industrials.

Against the trend, Pura Vida Investments opened a new position in Merck worth $5.45M.

  • Pura Vida Investments's largest Q1 2018 buy was Merck: 104,800 shares worth $5.45M.
  • Pura Vida Investments added most to Alexion Pharmaceuticals in Q1 2018, an estimated $3M increase.
  • Pura Vida Investments's biggest Q1 2018 reduction was Boston Scientific, cutting an estimated $3.87M.
  • Pura Vida Investments fully exited Dentsply Sirona in Q1 2018, selling an estimated $6.09M.
  • Pura Vida Investments's ten largest holdings make up 42% of its $169M portfolio in Q1 2018.
  • Pura Vida Investments opened 38 new positions and closed 41 in Q1 2018.
  • Pura Vida Investments's portfolio value fell 29% quarter-over-quarter to $169M.

Based on Pura Vida Investments's 13F filing for Q1 2018, filed 14 May 2018.